Intercure Return on Equity

Intercure (INCR) currently reports a ROE of -9.01%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Intercure's ROE history and peer comparisons.

Intercure's ROE of -9.01% is higher than the Healthcare sector average of -75.84%. That is roughly 88.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Intercure's current -9.01% should be judged against Healthcare norms (sector average: -75.84%) and against INCR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -9.01%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Intercure, and consider following INCR for alerts when major investors trade the stock.

Intercure is classified in the Healthcare sector. On ROE, it currently shows -9.01% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INCR with unrelated industries.